JESSICA SHEFFIELD: Open Payments
NPI 1942941224 · TRENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 37 payments from 10 companies in 2025. Trend: 2023 $93 · 2024 $0 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $188 |
| AstraZeneca Pharmaceuticals LP | 7 | $182 |
| GlaxoSmithKline, LLC. | 5 | $86 |
| Novo Nordisk Inc | 4 | $76 |
| Exact Sciences Corporation | 3 | $47 |
| ABBVIE INC. | 2 | $45 |
| Medtronic, Inc. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $29 |
| Philips North America LLC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: MOUNJARO, FARXIGA, BREZTRI, Rybelsus, TRELEGY ELLIPTA, AIRSUPRA, SHINGRIX, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
